Aye, AI Captain!

Arlene Dy-Co
{"title":"Aye, AI Captain!","authors":"Arlene Dy-Co","doi":"10.56964/pidspj20232402001","DOIUrl":null,"url":null,"abstract":"Before we say aye to an innovation whether in healthcare or other fields it is prudent to evaluate its merits and perils. The rapid rise of artificial intelligence (AI) has created both a growing excitement and cautious wary amongst many in the medical and research fields. And this includes the field of medical publishing. AI is being used today across different fields, also known as machine intelligence, it focuses on building and managing technology that can learn to autonomously make decisions and carry out actions on behalf of a person. As the technology has become more embedded in everyday applications, the interest focused on seeking to emulate the human brain through the design of programs and algorithms with real-time processing. Much debate about AI’s potential to revolutionize is countered with significant concerns. There are many areas in which AI is valuable in publishing from simple formatting, checking of grammar to the more complex like-text auto-tagging to improve discoverability of research and much more. It can improve and speed up many processes in the editorial workflow. Some of its potential drawbacks include concerns about privacy and data security, loss of personal touch and limited emotional connection, bias and possibly discriminatory algorithms and ethical concerns. Such that the International Committee of Medical Journal Editors (ICMJE) updated the criteria for authorship in the advent of AI. It states that chatbots should not be listed as authors because they cannot be responsible for the accuracy, integrity, and originality of a work, and these responsibilities are required for authorship. Authors should not list AI and AI-assisted technologies as an author or co-author, nor cite AI as an author. Further, ICMJE issued that journals should require authors to disclose whether they used artificial intelligence (AI)-assisted technologies in the production of submitted work. Authors who use such technology should describe, in both the cover letter and the submitted work, how they used it. While AI surely has an enormous potential for great advances much of their power comes from their ability to outperform human abilities in terms of speed and accuracy. I believe that AI’s existence in the medical publishing field is unavoidable. It is poised to have a dramatic influence in the way we share new discoveries, health advances and findings in research and innovations. At its best, it can spread landmark breakthroughs instantaneously but this makes accountability very critical to its application. I hope that measures will be employed to ensure that humans run the system—not the other way around.","PeriodicalId":117545,"journal":{"name":"Pediatric Infectious Disease Society of the Philippines Journal","volume":"2 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-11-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pediatric Infectious Disease Society of the Philippines Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.56964/pidspj20232402001","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Before we say aye to an innovation whether in healthcare or other fields it is prudent to evaluate its merits and perils. The rapid rise of artificial intelligence (AI) has created both a growing excitement and cautious wary amongst many in the medical and research fields. And this includes the field of medical publishing. AI is being used today across different fields, also known as machine intelligence, it focuses on building and managing technology that can learn to autonomously make decisions and carry out actions on behalf of a person. As the technology has become more embedded in everyday applications, the interest focused on seeking to emulate the human brain through the design of programs and algorithms with real-time processing. Much debate about AI’s potential to revolutionize is countered with significant concerns. There are many areas in which AI is valuable in publishing from simple formatting, checking of grammar to the more complex like-text auto-tagging to improve discoverability of research and much more. It can improve and speed up many processes in the editorial workflow. Some of its potential drawbacks include concerns about privacy and data security, loss of personal touch and limited emotional connection, bias and possibly discriminatory algorithms and ethical concerns. Such that the International Committee of Medical Journal Editors (ICMJE) updated the criteria for authorship in the advent of AI. It states that chatbots should not be listed as authors because they cannot be responsible for the accuracy, integrity, and originality of a work, and these responsibilities are required for authorship. Authors should not list AI and AI-assisted technologies as an author or co-author, nor cite AI as an author. Further, ICMJE issued that journals should require authors to disclose whether they used artificial intelligence (AI)-assisted technologies in the production of submitted work. Authors who use such technology should describe, in both the cover letter and the submitted work, how they used it. While AI surely has an enormous potential for great advances much of their power comes from their ability to outperform human abilities in terms of speed and accuracy. I believe that AI’s existence in the medical publishing field is unavoidable. It is poised to have a dramatic influence in the way we share new discoveries, health advances and findings in research and innovations. At its best, it can spread landmark breakthroughs instantaneously but this makes accountability very critical to its application. I hope that measures will be employed to ensure that humans run the system—not the other way around.
是,人工智能上尉!
在我们对医疗保健或其他领域的创新说 "是 "之前,最好先评估一下它的优点和危险。人工智能(AI)的迅速崛起让医疗和研究领域的许多人既兴奋又谨慎。这其中也包括医学出版领域。如今,人工智能已被广泛应用于各个领域,它也被称为机器智能,其重点是构建和管理能够学会自主决策并代表人采取行动的技术。随着这项技术越来越多地嵌入日常应用,人们的兴趣集中在通过设计具有实时处理功能的程序和算法来模拟人脑。对于人工智能的革命潜力,人们争论不休,但也有很多担忧。人工智能在出版业的许多领域都很有价值,从简单的格式、语法检查到更复杂的文本自动标记,以提高研究的可发现性等等。它可以改进和加快编辑工作流程中的许多环节。它的一些潜在缺点包括对隐私和数据安全的担忧、个人接触的丧失和有限的情感联系、偏见和可能的歧视性算法以及道德问题。因此,国际医学期刊编辑委员会(ICMJE)更新了人工智能时代的作者资格标准。它指出,聊天机器人不应被列为作者,因为它们无法对作品的准确性、完整性和原创性负责,而这些责任是作者身份的必要条件。作者不应将人工智能和人工智能辅助技术列为作者或共同作者,也不应引用人工智能为作者。此外,ICMJE 还规定,期刊应要求作者披露在所提交的作品中是否使用了人工智能 (AI) 辅助技术。使用此类技术的作者应在求职信和提交的作品中说明他们是如何使用的。虽然人工智能肯定有巨大的发展潜力,但其力量主要来自于其在速度和准确性方面超越人类的能力。我认为,人工智能在医学出版领域的存在是不可避免的。它将对我们分享新发现、健康进步以及研究和创新成果的方式产生巨大影响。在最好的情况下,它可以瞬间传播具有里程碑意义的突破,但这也使其应用的问责制变得非常关键。我希望能够采取措施,确保由人类来管理这个系统,而不是相反。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信